Echinococcosis: a review.

Echinococcosis in humans occurs as a result of infection by the larval stages of taeniid cestodes of the genus Echinococcus. In this review we discuss aspects of the biology, life cycle, etiology, distribution, and transmission of the Echinococcus organisms, and the epidemiology, clinical features, treatment, and effect of improved diagnosis of the diseases they cause. New sensitive and specific diagnostic methods and effective therapeutic approaches against echinococcosis have been developed in the last 10 years. Despite some progress in the control of echinococcosis, this zoonosis continues to be a major public health problem in several countries, and in several others it constitutes an emerging and re-emerging disease.

[1]  Cobo,et al.  Albendazole plus praziquantel versus albendazole alone as a pre‐operative treatment in intra‐abdominal hydatidosis caused by Echinococcus granulosus , 1998, Tropical medicine & international health : TM & IH.

[2]  Z. Pawłowski,et al.  Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). , 1989, Bulletin of the World Health Organization.

[3]  WHO Informal Working Group.  International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. , 2003, Acta tropica.

[4]  S. Reuter,et al.  In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis Larvae , 2006, Antimicrobial Agents and Chemotherapy.

[5]  Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. , 1996, Bulletin of the World Health Organization.

[6]  D. D. Heath,et al.  Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. , 1999, International journal for parasitology.

[7]  R. Rausch,et al.  Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos. , 1980, The American journal of tropical medicine and hygiene.

[8]  J. Little.  Hydatid disease at Royal Prince Alfred Hospital, 1964 to 1974. , 1976, The Medical journal of Australia.

[9]  J. Reichen,et al.  Human Alveolar Echinococcosis after Fox Population Increase, Switzerland , 2007, Emerging infectious diseases.

[10]  C. Fìlice,et al.  Use of PAIR in human cystic echinococcosis. , 1997, Acta tropica.

[11]  W. Gaus,et al.  Risk Factors for Alveolar Echinococcosis in Humans , 2004, Emerging infectious diseases.

[12]  P. Schantz,et al.  Echinococcal disease. , 1993, Infectious disease clinics of North America.

[13]  R. Ammann,et al.  Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). , 1990, The American journal of tropical medicine and hygiene.

[14]  L. Lindberg,et al.  DIAGNOSIS OF CYSTIC HYDATID DISEASE: ROLE OF ASPIRATION CYTOLOGY , 1988, The Lancet.

[15]  P. Torgerson.  Mathematical models for the control of cystic echinococcosis. , 2006, Parasitology international.

[16]  B. McMahon,et al.  Parasiticidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. McManus,et al.  Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans. , 2006, The Journal of infectious diseases.

[18]  T. Romig,et al.  Emergence/re-emergence of Echinococcus spp.--a global update. , 2005, International journal for parasitology.

[19]  S. Zargar,et al.  Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. , 1993, Gastroenterology.

[20]  D. Morris,et al.  Hydatid Disease: Current Medical and Surgical Management , 1992 .

[21]  C. Kapel,et al.  Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. , 2006, International journal for parasitology.

[22]  D. McManus,et al.  Genetic variation and epidemiology of Echinococcus granulosus in Argentina , 1999, Parasitology.

[23]  D. Didier,et al.  Hepatic alveolar echinococcosis: correlative US and CT study. , 1985, Radiology.

[24]  Little Jm.  Hydatid disease at Royal Prince Alfred Hospital, 1964 to 1974. , 1976 .

[25]  J. J. Bonilla,et al.  Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay , 2005, Parasitology Research.

[26]  A. Lymbery,et al.  Echinococcus and hydatid disease , 1995 .

[27]  G. Mantion,et al.  Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report , 2003, Transplantation.

[28]  P. Deplazes,et al.  Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern , 2004, Clinical Microbiology Reviews.

[29]  D. McManus,et al.  Recent advances in the immunology and diagnosis of echinococcosis. , 2006, FEMS immunology and medical microbiology.

[30]  M. Khuroo,et al.  Percutaneous drainage compared with surgery for hepatic hydatid cysts. , 1997, The New England journal of medicine.

[31]  U. Mackenstedt,et al.  The present situation of echinococcosis in Europe. , 2006, Parasitology international.

[32]  M. Beg,et al.  Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. McManus,et al.  Towards a taxonomic revision of the genus Echinococcus. , 2002, Trends in parasitology.

[34]  Louis Levis.  Epidemiology and control , 2002 .

[35]  D. McManus,et al.  Molecular epidemiology of cystic echinococcosis , 2003, Parasitology.

[36]  C. Fìlice,et al.  Echinococcosis in humans: clinical aspects, diagnosis and treatment. , 2001 .

[37]  D. C. Gomes,et al.  An autochthonous case of Echinococcus vogeli Rausch & Bernstein, 1972 polycystic echinococcosis in the state of Rondônia, Brazil. , 2002, Memorias do Instituto Oswaldo Cruz.

[38]  P. Schantz,et al.  Cystic echinococcosis in the Americas. , 2006, Parasitology international.

[39]  R. Gilman,et al.  Epidemiology of Echinococcus granulosus infection in the central Peruvian Andes. , 1997, Bulletin of the World Health Organization.

[40]  P. Schantz,et al.  Echinococcosis: historical landmarks and progress in research and control , 2006, Annals of tropical medicine and parasitology.

[41]  A. D'alessandro.  Polycystic echinococcosis in tropical America: Echinococcus vogeli and E. oligarthrus. , 1997, Acta tropica.

[42]  M. A. al Karawi,et al.  Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. , 1998, Hepato-gastroenterology.

[43]  C. Náquira,et al.  First report of a human case of polycystic echinococcosis due to Echinococcus vogeli from neotropical area of Peru, South America. , 2004, Revista do Instituto de Medicina Tropical de Sao Paulo.

[44]  L. Cabrera,et al.  Identification of risk factors for cystic echinococcosis in a peri-urban population of Peru. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[45]  N. Xiao,et al.  Echinococcus shiquicus, a new species from the Qinghai-Tibet plateau region of China: discovery and epidemiological implications. , 2006, Parasitology international.

[46]  J. Heslop.  Hydatid disease ‐ current medical and surgical management , 2005 .

[47]  L. Yarzábal,et al.  Principles of the surgical approach in human liver cystic echinococcosis. , 1997, Acta tropica.

[48]  U. Mackenstedt,et al.  Genetic characterization and phylogenetic position of Echinococcus felidis (Cestoda: Taeniidae) from the African lion. , 2008, International journal for parasitology.

[49]  R. J. Horton.  Chemotherapy of Echinococcus infection in man with albendazole. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[50]  L. Ma,et al.  Differential serodiagnosis for cystic and alveolar echinococcosis using fractions of Echinococcus granulosus cyst fluid (antigen B) and E. multilocularis protoscolex (EM18). , 1999, The American journal of tropical medicine and hygiene.

[51]  A. Farzad,et al.  Clinical Echinococcosis , 1975, Annals of surgery.

[52]  B. Frider,et al.  Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis , 2003, Parasitology.

[53]  D. D. Heath,et al.  Progress in control of hydatidosis using vaccination--a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. , 2003, Acta tropica.

[54]  D. Carmena,et al.  The immunodiagnosis of Echinococcus multilocularis infection. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[55]  Gail M. Williams,et al.  Community surveys and risk factor analysis of human alveolar and cystic echinococcosis in Ningxia Hui Autonomous Region, China. , 2006, Bulletin of the World Health Organization.

[56]  P. Georgiev,et al.  Factors influencing the response to chemotherapy in human cystic echinococcosis. , 1992, Bulletin of the World Health Organization.

[57]  R. Smego,et al.  Treatment options for hepatic cystic echinococcosis. , 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[58]  J. El-on.  Benzimidazole treatment of cystic echinococcosis. , 2003, Acta tropica.